SureTrader Nadex Advertisement PGUS
Home > Boards > Free Zone > All Fundamentals > $Pistol Pete$, $Mick$ & Friends Stock Picks /news, DD and charts

$PMCB UNC Researchers Progress on Cannabis Study to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
$Pistol Pete$ Member Profile
Member Level 
Followed By 1,802
Posts 169,923
Boards Moderated 109
Alias Born 05/06/14
160x600 placeholder
Correction to Intel New Drives Story on March 19
Intel claims the raw 3D XPoint technology is 1,000 times faster than the NAND flash commonly used in storage drives, though still about 10% the speed of temporary memory called DRAM, or dynamic random-access memory. "Intel Looks to Gain From Data Explosion With New Drives, published March 19 at 6:00 a.m. EDT, incorrectly stated in the fourth paragraph that the 3D XPoint is 1% the speed of DRAM. (March 23)
Shell Sells Gabon Onshore Interests in Debt-Cutting Drive
With Niche Sites, Wal-Mart Tries Selling to Hipsters
Divorced Couples, Put Aside Your Differences...for the Tax Break
Investec Bank plc Form 8.5 (EPT/RI) - Tesco Plc
FTSE 100 Set For Worst Week Since January As Investors Eye U.S. Health-care Bill
Top Company News of the Day
ECB's Praet Says Talk of Ending Loose Policy is 'Premature'
Top Company News of the Day
Smiths Group 1st Half Pretax Profit More Than Doubles
$Pistol Pete$ Member Level  Monday, 03/20/17 03:35:53 PM
Re: mick post# 123915
Post # of 124345 
$PMCB UNC Researchers Progress on Cannabis Study to Develop Cancer Treatments

http://www.unco.edu/news/releases.aspx?id=10173



Two scientific papers that will be presented this spring detail the progress of cannabis research aimed at developing targeted cancer treatments as part of an ongoing study led by University of Northern Colorado professor Richard Hyslop.

Hyslop and a team of UNC scientists that includes chemistry students are investigating the feasibility of PharmaCyte Biotech Inc.'s patented cell encapsulation technology for treating cancer and diabetes. Initial results suggest that cannabis compounds possess potent anti-proliferative effects against several types of cancer cells. Researchers to date have observed five cell lines that produce desired enyzmes to convert inactive cannabis compounds into anti-cancer drugs once they're injected and then activated directly at the site of a tumor.

The group has submitted proposals to present the papers at the American Chemical Society National Meeting, April 2-6 in San Francisco. The titles of the papers are: "Development of a cannabinoid-based Cell-in-a-Box therapeutic system targeted toward malignant tumors" and "In vitro anti-neoplastic activity of specific phytocannabinoids of Cannabis sativa."

Hyslop has been involved in cancer research for four decades and is leading a team of scientists from UNC to develop a "green" approach to treating solid tumors, initially brain cancer.

"We are looking forward to sharing some of our results with the scientific community," Hyslop said. "Our team of biochemists, organic chemists, molecular biologists, genetic engineers, undergraduate students, and graduate students continue to work diligently to achieve our goal of developing targeted cannabinoid-based chemotherapy utilizing Cell-in-a-Box."

PharmaCyte's chief executive officer Kenneth L. Waggoner added: "We are very pleased with the ongoing progress at UNC. The upcoming ACS meeting provides an ideal venue to present two more scientific papers that have been generated from the work being done by Dr. Hyslop and his students as well as showcase the versatility of Cell-in-a-Box as an advanced therapeutic platform."




investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist